10 research outputs found

    Genetic relatedness versus biological compatibility between Aspergillus fumigatus and related species

    No full text
    Aspergillus section Fumigati contains 12 clinically relevant species. Among these Aspergillus species, A. fumigatus is the most frequent agent of invasive aspergillosis, followed by A. lentulus and A. viridinutans. Genealogical concordance and mating experiments were performed to examine the relationship between phylogenetic distance and mating success in these three heterothallic species. Analyses of 19 isolates from section Fumigati revealed the presence of three previously unrecognized species within the broadly circumscribed species A. viridinutans. A single mating type was found in the new species Aspergillus pseudofelis and Aspergillus pseudoviridinutans, but in Aspergillus parafelis, both mating types were present. Reciprocal interspecific pairings of all species in the study showed that the only successful crosses occurred with the MAT1-2 isolates of both A. parafelis and A. pseudofelis. The MAT1-2 isolate of A. parafelis was fertile when paired with the MAT1-1 isolates of A. fumigatus, A. viridinutans, A. felis, A. pseudoviridinutans, and A. wyomingensis but was not fertile with the MAT1-1 isolate of A. lentulus. The MAT1-2 isolates of A. pseudofelis were fertile when paired with the MAT1-1 isolate of A. felis but not with any of the other species. The general infertility in the interspecies crossings suggests that genetically unrelated species are also biologically incompatible, with the MAT1-2 isolates of A. parafelis and A. pseudofelis being the exception. Our findings underscore the importance of genealogical concordance analysis for species circumscription, as well as for accurate species identification, since misidentification of morphologically similar pathogens with differences in innate drug resistance may be of grave consequences for disease management

    Genetic Analysis Using an Isogenic Mating Pair of <i>Aspergillus fumigatus</i> Identifies Azole Resistance Genes and Lack of <i>MAT</i> Locus’s Role in Virulence

    No full text
    <div><p>Invasive aspergillosis (IA) due to <i>Aspergillus fumigatus</i> is a major cause of mortality in immunocompromised patients. The discovery of highly fertile strains of <i>A</i>. <i>fumigatus</i> opened the possibility to merge classical and contemporary genetics to address key questions about this pathogen. The merger involves sexual recombination, selection of desired traits, and genomics to identify any associated loci. We constructed a highly fertile isogenic pair of <i>A</i>. <i>fumigatus</i> strains with opposite mating types and used them to investigate whether mating type is associated with virulence and to find the genetic loci involved in azole resistance. The pair was made isogenic by 9 successive backcross cycles of the foundational strain AFB62 (<i>MAT1-1</i>) with a highly fertile (<i>MAT1-2</i>) progeny. Genome sequencing showed that the F<sub>9</sub><i>MAT1-2</i> progeny was essentially identical to the AFB62. The survival curves of animals infected with either strain in three different animal models showed no significant difference, suggesting that virulence in <i>A</i>. <i>fumigatus</i> was not associated with mating type. We then employed a relatively inexpensive, yet highly powerful strategy to identify genomic loci associated with azole resistance. We used traditional <i>in vitro</i> drug selection accompanied by classical sexual crosses of azole-sensitive with resistant isogenic strains. The offspring were plated under varying drug concentrations and pools of resulting colonies were analyzed by whole genome sequencing. We found that variants in 5 genes contributed to azole resistance, including mutations in <i>erg11A</i> (<i>cyp51A</i>), as well as multi-drug transporters, <i>erg25</i>, and in HMG-CoA reductase. The results demonstrated that with minimal investment into the sequencing of three pools from a cross of interest, the variation(s) that contribute any phenotype can be identified with nucleotide resolution. This approach can be applied to multiple areas of interest in <i>A</i>. <i>fumigatus</i> or other heterothallic pathogens, especially for virulence associated traits.</p></div

    Genomic comparison of AFB62F9 and AFB62.

    No full text
    <p>(A) Whole genome coverage plot using AFB62F9 reads mapped to the AFB62 genome showing percent identity (y-axis) per chromosome (x-axis). The red line and dots represents regions of the AFB62 genome covered by AFB62F9 reads at greater than 90% identity. (B) Close-up of mapped reads to the region surrounding the <i>MAT1-2</i> locus in AFB62. Numbers on top are coordinates on contig 677 (coordinates 1495670–1582078 on chromosome III). Top track in dark blue: average coverage of the genome was 48X with a maximum of 56 read coverage. The <i>MAT1-2</i> locus in AFB62F9 had no mapped reads so the coverage drops to 0X (~27 Kb in this figure). Second track: SNP density per 1,000 bp is depicted as a red histogram. Maximum SNP/Kb was 10. Note the sharp increase surrounding the <i>MAT1-1</i> locus and extending in the 3’ direction for an additional ~230Kb not depicted in this figure. Bottom track: annotated protein-coding genes in the AFB62 assembly. Direction of arrows depicts the coding strand.</p

    Variant allele frequencies of relevant mutations in sequenced pools of mating offspring under no drug, intermediate, and high-level selection for each drug.

    No full text
    <p><sup>a</sup> The listed resistant strain was mated with the isogenic sensitive strain of the opposite mating type. (e.g. AFB62I11 (ItrR) was mated with AFB62F9)</p><p><sup>b</sup> 1: represents a variant allele frequency of 1 (i.e. only the mutant SNP was found). 0.5: represents a 1:1 ratio of the reference and mutant alleles. Ref: signifies only the reference allele was detected in the pool.</p><p><sup>c</sup> Mutations associated with the resistance phenotype because they followed the expected pattern are highlighted in bold. All blank cells represent the reference allele and were left blank because those mutations were not relevant in a given cross.</p><p>Variant allele frequencies of relevant mutations in sequenced pools of mating offspring under no drug, intermediate, and high-level selection for each drug.</p

    Azole resistance experimental design.

    No full text
    <p>(A) Sensitive AFB62 or AFB62F9 cells were incubated on solid media containing sub-MIC concentrations of each of itraconazole, voriconazole, or posaconazole. Resulting spores were plated on selective media with at least 1X MIC of each antifungal to obtain fewer than 100 colonies. Three resistant colonies (purple) from each selective plate were subsequently and independently plated on highly selective plates containing 10 – 50X MIC of each antifungal. Three highly resistant strains (purple) were selected for sequencing and for sexual crosses. (B) Each of the highly resistant isolates from (A) was crossed with the sensitive isogenic strain of the opposite mating type. Ascospores from selected crosses were grown on media with no drug, 1X MIC and 10X MIC of the drug and their DNA sequenced to identify resistance allele frequencies. Mutant alleles are depicted in purple and yellow reference alleles in green. Cells filled with a single color represent an allele frequency of 1, cells with two colors represent an equal proportion of mutant and reference alleles. The purple mutation shows the expected frequencies for an allele associated with resistance, while the yellow mutation shows an expected frequency for alleles not associated with resistance.</p

    Virulence studies in murine and larvae models.

    No full text
    <p>Mice with chronic granulomatous disease (CGD) (A), hydrocortisone treated BALB/c mice (B) and <i>Galleria mellonella</i> larvae (C) were inoculated with <i>Aspergillus fumigatus MAT1-1</i> (AFB62) or <i>MAT1-2</i> (AFB62F9) strains. CGD (5 mice per group) and BALB/c (10 mice per group) mice received 30 ÎĽl of 3.33x10<sup>5</sup> and 3.33x10<sup>7</sup> conidia/ml, respectively, via pharyngeal aspiration. Larvae (15 larvae per group) were injected with 5 ÎĽl of 2x10<sup>7</sup> conidia/ml. Survival data was analyzed using log rank test.</p

    Lungs of mice with chronic granulomatous disease (CGD) or hydrocortisone-treated BALB/c mice inoculated with <i>Aspergillus fumigatus</i> isogenic strains, AFB62 and AFB62F9.

    No full text
    <p>(A-D) Lungs of CGD mice. (E-H) Lungs of hydrocortisone-treated BALB/c mice. (A, B, E and F) Lungs of mice inoculated with AFB62. (C, D, G and H) Lungs of mice inoculated with AFB62F9. Numerous granulomas (A and C) with extensive hyphal growth (B and D) are seen in the lungs of CGD mice at nine days post fungal inoculation. Extensive hyphal growth (arrows in F and H) is seen in the bronchial tree in lungs of hydrocortisone-treated BALB/c mice at seven days post fungal inoculation. CGD and hydrocortisone-treated BALB/c mice were inoculated with 30 ÎĽl of 3.33x10<sup>5</sup> and 3.33x10<sup>7</sup> conidia/ml, respectively, via pharyngeal aspiration. Sections were stained with hematoxylin and eosin (A, C, E and G) and Gomori methenamine silver (B, D, F and H).</p

    Total number of SNP of sequenced AFB62 or AFB62F9 intermediate (bold) and high level resistant isolates in itraconazole, posaconazole, or voriconazole after in vitro selection.

    No full text
    <p>Number of mutations in relevant genes <i>erg11A</i>, <i>erg25A</i>, <i>hmg1</i>, <i>ssc70</i>, <i>ganA</i>, and the ABC transporter (AFUA_92.m00226) are presented. Strains in <b>bold</b> were selected under intermediate drug concentrations, strain in <i>italics</i> were direct derivatives of strains in bold selected at high drug concentrations. Numbers in parentheses refer to the number of individual SNPs identified in each gene. Details on the specific mutations are found in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1004834#ppat.1004834.s006" target="_blank">S4 Table</a>. Itra—itraconazole, Posa—posaconazole, Vori—voriconazole.</p><p>Total number of SNP of sequenced AFB62 or AFB62F9 intermediate (bold) and high level resistant isolates in itraconazole, posaconazole, or voriconazole after in vitro selection.</p
    corecore